1. Virotherapy in Germany—Recent Activities in Virus Engineering, Preclinical Development, and Clinical Studies
   Dirk M. Nettelbeck et al, 2021, Viruses CrossRef
2. Sequencing of serially passaged measles virus affirms its genomic stability and reveals a nonrandom distribution of consensus mutations
   Mathias Felix Leber et al, 2020, Journal of General Virology CrossRef
3. Redirecting the Immune Microenvironment in Acute Myeloid Leukemia
   Stephanie Sendker et al, 2021, Cancers CrossRef
4. Improved Production Strategies for Oncolytic Measles Viruses as a Therapeutic Cancer Treatment
   Dustin Eckhardt et al, 2023, Bioprocess and Analytics Development for Virus-based Advanced Therapeutics and Medicinal Products (ATMPs) CrossRef
5. Cancer Nanopharmaceuticals: Physicochemical Characterization and In Vitro/In Vivo Applications
   Aleksandra Zielińska et al, 2021, Cancers CrossRef
6. Engineering and combining oncolytic measles virus for cancer therapy
   Mathias F. Leber et al, 2020, Cytokine & Growth Factor Reviews CrossRef
7. Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
   Vanessa Innao et al, 2020, Current Oncology CrossRef